About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

New Biomarkers Evaluating Ovarian Cancer

NCT01466049·2 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Fujirebio Diagnostics, Inc.

Age

18–any

Sex

FEMALE

Healthy volunteers

Not accepted

You may be eligible if

Female, age 18 years or older
Adnexal mass present documented by imaging
Scheduled to undergo surgery based on a finding of adnexal mass
Able and willing to provide Informed Consent

You may not be if

Previous history of ovarian cancer
Previous history of bilateral oophorectomy
Currently known to be pregnant
Unable to provide informed consent

The record

StatusCompleted

PhaseNo phase

Taking part280

StartedDec 2011

UpdatedAug 5, 2014

Conditions

Where2

New Hanover Regional Medical Center
Wilmington, North Carolina, United States
University of Oklahoma
Oklahoma City, Oklahoma, United States

Clareo Health | New Biomarkers Evaluating Ovarian Cancer